226 related articles for article (PubMed ID: 35036121)
1. Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.
Yan Z; Chu S; Zhu C; Han Y; Liang Q; Shen S; Cheng W; Wu A
PeerJ; 2021; 9():e12547. PubMed ID: 35036121
[TBL] [Abstract][Full Text] [Related]
2. T cell exhaustion assessment algorism in tumor microenvironment predicted clinical outcomes and immunotherapy effects in glioma.
Chen L; Fu B
Front Genet; 2022; 13():1087434. PubMed ID: 36531217
[TBL] [Abstract][Full Text] [Related]
3. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.
Deng L; Ren J; Li B; Wang Y; Jiang N; Wang Y; Cui H
BMC Genomics; 2023 Dec; 24(1):746. PubMed ID: 38057698
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
Ren W; Jin W; Liang Z
Front Neurol; 2022; 13():832944. PubMed ID: 35370869
[TBL] [Abstract][Full Text] [Related]
8. Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma.
Hou Z; Luo D; Luo H; Hui Q; Xu Y; Lin X; Xu Z
Ann Med; 2023 Dec; 55(1):778-792. PubMed ID: 36856519
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
[TBL] [Abstract][Full Text] [Related]
11. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma.
Liu R; Liang W; Hua Q; Wu L; Wang X; Li Q; Zhong F; Li B; Qiu Z
Front Immunol; 2022; 13():819515. PubMed ID: 35251000
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
13. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
[No Abstract] [Full Text] [Related]
14. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
15. Immunological classification of glioblastoma and its prognostic implications.
Wang Q; Lin W; Liu T; Hu J; Zhu Y
Am J Transl Res; 2022; 14(11):8009-8022. PubMed ID: 36505340
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma.
Liu H; Shi K; Wei Z; Zhang Y; Li J
Heliyon; 2024 May; 10(10):e31207. PubMed ID: 38813229
[TBL] [Abstract][Full Text] [Related]
17. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma.
Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H
Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.
Wang H; Li Z; Ou S; Song Y; Luo K; Guan Z; Zhao L; Huang R; Yu S
Front Mol Biosci; 2022; 9():884839. PubMed ID: 35836930
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma.
Tian Z; Yang Z; Jin M; Ding R; Wang Y; Chai Y; Wu J; Yang M; Zhao W
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13185-13200. PubMed ID: 37479756
[TBL] [Abstract][Full Text] [Related]
20. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
